# Retatrutide phase 2 trial: weight loss at 48 weeks

Source: https://pepvault.app/research/retatrutide-jastreboff-2023

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Retatrutide](https://pepvault.app/research#retatrutide)

Randomized trial · people

# Retatrutide: 24.2% weight loss at 48 weeks in the 12 mg arm

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this 48-week trial, weight loss with retatrutide grew with dose, gut side effects were the most common, and a lower starting dose partly eased them.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 338
- **Published:** 2023
- **Journal:** N Engl J Med

## What they tested

The team wanted to learn how different weekly doses of retatrutide relate to weight loss, side effects and safety in adults with obesity.

## How the study was done

A phase 2, double-blind, randomized, placebo-controlled trial in 338 adults with a BMI (body-mass index, weight relative to height) of 30 or higher, or 27 to under 30 with at least one weight-related condition. Participants got a weekly shot under the skin of retatrutide at 1 mg, 4 mg, 8 mg or 12 mg (some arms started at a lower dose) or placebo, a dummy shot, for 48 weeks.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At 24 weeks, the main goal, average body weight changed by -7.2% in the 1 mg arm, -12.9% in the combined 4 mg arms, -17.3% in the combined 8 mg arms and -17.5% in the 12 mg arm, compared with -1.6% on placebo. At 48 weeks, the changes were -8.7%, -17.1%, -22.8% and -24.2%, compared with -2.1% on placebo. By 48 weeks, a loss of 15% or more was seen in 60% of the 4 mg group, 75% of the 8 mg group and 83% of the 12 mg group, compared with 2% on placebo. Stomach and gut side effects were the most common, rose with dose, were mostly mild to moderate and were partly eased by starting at 2 mg instead of 4 mg. Heart rate also went up with dose, peaked at 24 weeks and then came down.

## What it doesn’t show

This was a mid-stage trial of 338 people lasting 48 weeks, so it doesn't show longer-term results or rarer side effects. It was funded by Eli Lilly.

## The paper

Jastreboff et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial. N Engl J Med. 2023.

- [PubMed (PMID 37366315)](https://pubmed.ncbi.nlm.nih.gov/37366315/)
- [The paper (DOI 10.1056/NEJMoa2301972)](https://doi.org/10.1056/NEJMoa2301972)
- [ClinicalTrials.gov (NCT04881760)](https://clinicaltrials.gov/study/NCT04881760)

## The compound

- [Retatrutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026)
- [All 12 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on Retatrutide

- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025) Meta-analysis · people · 2025
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026) Randomized trial · people · 2026
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026) Randomized trial · people · 2026
- [Retatrutide: 26.1% fat mass loss at 36 weeks in type 2 diabetes](https://pepvault.app/research/retatrutide-coskun-2025) Randomized trial · people · 2025
- [Retatrutide: up to 82.4% less liver fat at 24 weeks in MASLD trial](https://pepvault.app/research/retatrutide-sanyal-2024) Randomized trial · people · 2024
- [Retatrutide: up to 8.96 kg placebo-adjusted weight loss in 12 weeks](https://pepvault.app/research/retatrutide-urva-2022) Randomized trial · people · 2022
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Retatrutide

- [Retatrutide: the full reference](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-15mg)
- [20 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-20mg)
- [24 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-24mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-30mg)
- [40 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-40mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/retatrutide-60mg)

### Studies

- [Retatrutide: top odds of 15% or more weight loss across 19 trials](https://pepvault.app/research/retatrutide-sinha-2025)
- [Retatrutide: non-HDL cholesterol down up to 26.9% in phase 2 trials](https://pepvault.app/research/retatrutide-ruotolo-2026)
- [Retatrutide: up to 25.0% weight loss at 80 weeks in TRIUMPH-1](https://pepvault.app/research/retatrutide-triumph-1-2026)
- [All 12 studies](https://pepvault.app/research#retatrutide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Survodutide vs Retatrutide](https://pepvault.app/peptides/compare/survodutide-vs-retatrutide)
- [Retatrutide vs Orforglipron](https://pepvault.app/peptides/compare/retatrutide-vs-orforglipron)
- [Retatrutide vs Mazdutide](https://pepvault.app/peptides/compare/retatrutide-vs-mazdutide)
- [Retatrutide vs Cagrilintide](https://pepvault.app/peptides/compare/retatrutide-vs-cagrilintide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking retatrutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Retatrutide](https://pepvault.app/research#retatrutide)

## The library

- [Retatrutide](https://pepvault.app/peptides/retatrutide)
- [Retatrutide dose guide](https://pepvault.app/lab/dosage/retatrutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
